1. Guest, the 'News in Brief' for the week beginning 29th May 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2020, Watanabe

Discussion in 'ME/CFS research' started by Dolphin, Nov 8, 2022.

  1. Dolphin

    Dolphin Senior Member (Voting Rights)


    PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, debilitating disorder with a wide spectrum of symptoms, including fatigue, pain, depression and neurocognitive deterioration. Over 17 million people around the world have ME/CFS, predominantly women with peak onset at 30–50 years. Given the wide spectrum of symptoms and unclear etiology, specific biomarkers for diagnosis and stratification of ME/CFS are lacking. Here the results from PET/SPECT/MRI/fMRI studies are reviewed to understand the pathophysiology and to develop therapies of this severe syndrome.

    • Myalgic encephalomyelytis/chronic fatigue syndrome
    • Brain morphometry
    • Connectivity
    • Regional cerebral blood flow
    • Glucose utilization rate
    • Serotonergic deterioration
    • Neuroinflammation
    • Repair energy loss

    I've heard it's available here: https://sci-hub.se/
    Last edited by a moderator: Nov 8, 2022
  2. livinglighter

    livinglighter Senior Member (Voting Rights)

    Peter Trewhitt and Dolphin like this.

Share This Page